Recent evidence suggests that angiotensin-(1-7) is a bioactive component of
the renin-angiotensin system that may oppose or, in certain situations con
tribute to the actions of Ang II. Ang-(1-7) can be directly formed from Ang
I bypassing the requisite production of Ang II. In contrast to forming Ang
II, angiotensin-converting enzyme hydrolyses Ang-(1-7) to inactive fragmen
ts. Angiotensin-converting enzyme inhibitors substantially augment circulat
ing levels of Ang-(1-7) and increase the peptide's half-life six-fold. Thus
, angiotensin-converting enzyme may constitute an important regulatory poin
t to balance the actions of Ang II, Ang-(1-7) and bradykinin. Indeed, Ang-(
1-7) can potentiate the actions of bradykinin through a receptor-mediated s
ite and a direct interaction with angiotensin-converting enzyme. We summari
ze recent studies that reveal depressor, vasodilator, and antihypertensive
actions of Ang-(1-7) thus providing evidence that Ang-(1-7) is the antihype
rtensive peptide of the renin-angiotensin system. Curr Opin Nephrol Hyperte
ns 8:231-235. (C) 1999 Lippincott Williams & Wilkins.